Weissella paramesenteroides WpK4 plays an immunobiotic role in gut-brain axis, reducing gut permeability, anxiety-like and depressive-like behaviors in murine models of colitis and chronic stress

作者: Sávio Sandes , Naiara Figueiredo , Sílvia Pedroso , Felipe Sant'Anna , Leonardo Acurcio

DOI: 10.1016/J.FOODRES.2020.109741

关键词: ColitisChronic stressUlcerative colitisImmunologyInflammatory bowel diseaseIntestinal permeabilityProbioticMedicineGut–brain axisMood disorders

摘要: The relationship between inflammatory bowel disease (IBD) and mood disorders is complex involves overlapping metabolic pathways, which may determine comorbidity. Several studies have been shown that this comorbidity could worsen IBD clinical course. treatment of ulcerative colitis complex, traditional therapy to promote the function epithelial barrier, reducing exacerbated responses. Recently, it has some probiotic strains modulate gut-brain axis, depressive anxiety scores in humans, including patients. Accordingly, study aimed evaluate role Weissella paramesenteroides WpK4 murine models chronic stress. It was observed bacterium ingestion improved health mice, intestinal permeability, besides improving colon histopathological appearance. In stressed bacterial consumption associated with a reduced anxiety-like depressive-like behaviors. both assays, beneficial W. related its immunomodulatory feature. possible state exerted their roles axis through effects consequences several pathways permeability hippocampal physiology.

参考文章(61)
Shiv Pillai, Abul K. Abbas, Andrew H. Lichtman, Cellular and Molecular Immunology ,(1994)
Ghodarz Akkasheh, Zahra Kashani-Poor, Maryam Tajabadi-Ebrahimi, Parvaneh Jafari, Hossein Akbari, Mohsen Taghizadeh, Mohammad Reza Memarzadeh, Zatollah Asemi, Ahmad Esmaillzadeh, Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. ,vol. 32, pp. 315- 320 ,(2016) , 10.1016/J.NUT.2015.09.003
Marta Martin-Subero, George Anderson, Buranee Kanchanatawan, Michael Berk, Michael Maes, Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. Cns Spectrums. ,vol. 21, pp. 184- 198 ,(2016) , 10.1017/S1092852915000449
Alicia A Walf, Cheryl A Frye, The use of the elevated plus maze as an assay of anxiety-related behavior in rodents Nature Protocols. ,vol. 2, pp. 322- 328 ,(2007) , 10.1038/NPROT.2007.44
Lesley A. Graff, John R. Walker, Charles N. Bernstein, Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflammatory Bowel Diseases. ,vol. 15, pp. 1105- 1118 ,(2009) , 10.1002/IBD.20873
Elisa Deriu, Janet Z. Liu, Milad Pezeshki, Robert A. Edwards, Roxanna J. Ochoa, Heidi Contreras, Stephen J. Libby, Ferric C. Fang, Manuela Raffatellu, Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron Cell Host & Microbe. ,vol. 14, pp. 26- 37 ,(2013) , 10.1016/J.CHOM.2013.06.007
L Desbonnet, G Clarke, F Shanahan, T G Dinan, J F Cryan, Microbiota is essential for social development in the mouse Molecular Psychiatry. ,vol. 19, pp. 146- 148 ,(2014) , 10.1038/MP.2013.65
Katharina Gerlach, Andrew N McKenzie, Markus F Neurath, Benno Weigmann, IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis. Tissue barriers. ,vol. 3, pp. 0- ,(2015) , 10.4161/21688370.2014.983777
L MP Loonen, E H Stolte, M TJ Jaklofsky, M Meijerink, J Dekker, P van Baarlen, J M Wells, REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunology. ,vol. 7, pp. 939- 947 ,(2014) , 10.1038/MI.2013.109
Timothy G. Dinan, Catherine Stanton, John F. Cryan, Psychobiotics: a novel class of psychotropic. Biological Psychiatry. ,vol. 74, pp. 720- 726 ,(2013) , 10.1016/J.BIOPSYCH.2013.05.001